Table 3.
Correlation between clinicopathological features and UCAD results in 29 patients with biliary tract cancer.
| N | % | UCAD (+) | UCAD (-) | P valuea | |
|---|---|---|---|---|---|
| No. patients | 29 | 26 | 3 | ||
| Cancer type | 0.176 | ||||
| Gallbladder cancer | 8 | 27.6 | 6 | 2 | |
| Cholangiocarcinoma | 21 | 72.4 | 20 | 1 | |
| TNM Stage | > 0.999 | ||||
| Stage I | 3 | 13.8 | 3 | 0 | |
| Stage II | 4 | 10.3 | 4 | 0 | |
| Stage III | 14 | 48.3 | 12 | 2 | |
| Stage IV | 8 | 27.6 | 7 | 1 | |
| Perineural invasion | 21 | 72.4 | 19 | 2 | > 0.999 |
| Vascular invasion | 7 | 24.14 | 7 | 0 | 0.557 |
| Lymph node metastasis | 16 | 55.17 | 15 | 1 | 0.573 |
| Poor histological grade | 3 | 10.34 | 3 | 0 | > 0.999 |
| Distant metastasis | 2 | 6.90 | 2 | 0 | > 0.999 |
BTC, biliary tract cancer.
Bold values indicate statistical significance (P < 0.05).
Fisher exact test.